Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients
Crossref DOI link: https://doi.org/10.1007/s12094-015-1425-5
Published Online: 2015-11-09
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yadav, P.
Masroor, M.
Tanwer, K.
Mir, R.
Javid, J.
Ahmad, I.
Zuberi, M.
Kaza, R. C. M.
Jain, S. K.
Khurana, N.
Ray, P. C.
Saxena, A.
Text and Data Mining valid from 2015-11-09